Cardiopulmonary Exercise Testing Market will grow at CAGR of 4.40% to hit $4.98 Billion by 2022-2030
The cardiopulmonary exercise testing market is expected to reach USD 4.98 billion by 2030 at 4.40% CAGR during the forecast period 2022-2030. The market value of the Cardiopulmonary exercise testing is growing day by day. This testing helps in detecting disorders related to the heart and lungs which are the major internal organs.
There has been a worldwide spike in the number of patients suffering from cardiopulmonary disorders. Therefore to check and maintain the health conditions of such patients cardiopulmonary exercise testing systems play an important role.
Mostly related to lifestyle change and rising pollution levels, heart, and lung-related disorders have become a serious issue. Many healthcare research labs are spending a lot of resources to develop user-friendly and accurate testing devices.
Covid 19 Analysis of Cardiopulmonary Exercise Testing Market
Covid brought a huge change in the market valuation of the cardiopulmonary testing market. While due to a sudden spike in the number of covid cases, the industry was unable to meet the rising demand. Disruptions in the supply chain owing to restrictions were the major growth hindering factor.
The demand shot up for both costly large testing machines and small pocket testing devices too. Small handy devices to monitor oxygen saturation, blood pressure, temperature such as oximeters were in higher demand. The cardiopulmonary exercise testing market is expected to surpass the pre covid growth rate quickly.
Cardiopulmonary Exercise Testing Market Dynamics
Cardiopulmonary problems are being more common among people of different regions owing to lifestyle changes. Moreover, these problems are more common in developed countries, thus the demand is significant in such countries. To cope up with rising cases, healthcare institutes are swiftly adopting cardiopulmonary exercise testing ( CPET ).
Another fueling factor for the rise is the technological advancements in the field of medicine. Cardiopulmonary exercise testing can detect the disorders in their early stage and pave the way for correct treatment. It can direct the medicinal practitioner towards a specific problem rather than going for a general treatment. Therefore, this exercise testing greatly enhances the success rate of a treatment.
The rise in disposable income of people in developing countries and also in patients count will be driving the growth. Moreover, a rise in the agile population who are more prone to such disorders in different countries will too generate the demand.
The major hindrance to the growth of the Cardiopulmonary exercise testing market is the cost factor. The high cost of exercising systems and analyzing devices is still much higher for small hospitals and diagnostic centers.
On the other hand, the shortage of skilled workers and analysts for operating the system also restricts the growth of the market. Lack of general awareness among people about such testings and negligence towards medical treatment are negative factors too.
Cardiopulmonary exercise testing evaluates the performance and health of the heart and lungs for patients suffering from cardiopulmonary disorders. Cardiopulmonary disorders are problems related to the heart and lungs. This tool tests the performance of both the organs at rest and at during exercise to show the deviation from normal behavior. The patient is required to run a stationary bicycle ergometer with superficial electrodes in his chest to measure electrical pulses in the heart. Moreover, his gas exchange capacity is monitored using special tube masks.
Cardiopulmonary exercise testings give insightful data to the doctors and can also predict future conditions. Such testing also incorporates a large number of general testings such as pulse rate, electrocardiography, etc. Therefore it will help in greatly reducing the general diagnosis and monitoring costs. Moreover, the development of handy and user-friendly testing products will enable the patients to monitor their health status themselves.
This report aims to provide an in-depth market analysis of the cardiopulmonary exercise testing. The specific objectives of this cardiopulmonary exercise testing market report are given below:
Cardiopulmonary Exercise Testing Monitors Market Share, by Product, 2017 (%)
Source: MRFR Analysis Regional Analysis
Segmentation of the Global cardiopulmonary exercise testing market, by Product
The cardiopulmonary exercise testing (CPET) system occupies the largest global market share. This is due to their handy design, multiple uses, and affordability. These cost-effective systems greatly simplify the work of physicians. However, pulse oximeters were in great demand recently owing to covid fear and are likely to continue the growth further.
Segmentation of Global Cardiopulmonary Exercise Testing Market, by End User
Hospitals and clinics occupy the largest share of the Global cardiopulmonary exercise testing market. As hospitals are the primary place where people visit for their treatment the demand will continue rising from here. The modernization of healthcare facilities by governments in different developing countries is also likely to fuel the demand. However, Diagnostics Centres are being successful in gathering the trust of the people. Hence, this segment is showing a higher growth rate
Cardiopulmonary Exercise Testing Market Share, by Region, 2017 (%)
Source: MRFR Analysis
Cardiopulmonary Exercise Testing Market Regional Analysis
Rest of the world ( RoW )
The Americas hold the largest share in the global pulmonary exercise testing market. The prevalence of cardiovascular disorders such as a coronary artery, cardiac arrest, heart failure, angina pectoris, etc. has made people conscious about their heart health. Moreover, good healthcare infrastructure also supports the growth of the market. Rising awareness about a healthy lifestyle and the need to monitor health is going to raise the demand.
Next to the Americas, Europe is the second-largest market. Governments' greater initiatives on health and wellness in this region are supporting the market growth of the cardiopulmonary exercise testing. Moreover, the prevalence of medical R&D Institutes is responsible for the development of innovative and user-friendly exercise testing devices and systems. Furthermore, the high disposable income of people and awareness about cardiac health are also the driving factors for the growth.
The Asia Pacific is the third-largest cardiopulmonary exercise testing market. Rising disposable incomes is bringing more people under the healthcare management system. Additionally lesser manufacturing costs of different devices and low labor costs are sustaining the growth.
The market value in the Middle East and Africa is also expected to rise during the forecast period. Economical development in these regions is expected to fuel the growth
The global cardiopulmonary exercise testing market is dominated by many medical device manufacturers. The key global players are:-
In August 2019, a leading US pulmonary medical firm, Vyaire medical Inc got FDA approval for two pulmonary function testing devices. These devices named Vyntus One and Vyntus Body, are a new addition to its existing Vyntus line.
This report will be beneficial for market stakeholder of the cardiopulmonary exercise testing. It will help in decision making for those directly connected with the industry such as :
Manufacturers of Cardiopulmonary testing systems
Medi care Companies
Traders of healthcare devices
This report provides complete details on the market of cardiopulmonary exercise testing in terms of current value and future forecast. We have also identified the problems and prospects of the given market.
Moreover, technological analysis of the product will help in knowing the product better and in decision making. Furthermore, this report contains a detailed analysis of every segment of the given market for the current forecast period. This report has also highlighted the key players and the current developments in the cardiopulmonary exercise testing market.
|Market Size||USD 1450 million|
|Forecast Units||Value (USD Million)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||Product and End User|
|Geographies Covered||North America, Europe, Asia-Pacific, and Rest of the World (RoW)|
|Key Vendors||Cardinal Health, COSMED SRL, GE Healthcare, Halma PLC, Hill-Rom Holdings, Inc., Koninklijke Philips NV, MGC Diagnostics Corporation, NIHON KOHDEN CORPORATION, Schiller AG, Masimo Corporation, and Vyaire Medical, Inc|
|Key Market Opportunities||Rising older population highly prone to degenerative diseases and chronic illnesses|
|Key Market Drivers||
The CAGR would be 4.40% for the forecast period.
The valuation would be USD 4.98 billion by 2030.
The Americas would ensure their domination during the forecast period.
Low cost of labor, developing healthcare, better funding from global players, and others would trigger growth.
The players involved are GE Healthcare, Cardinal Health, COSMED SRL, Hill-Rom Holdings, Inc., Halma PLC, MGC Diagnostics Corporation, Koninklijke Philips NV, Masimo Corporation, NIHON KOHDEN CORPORATION, Schiller AG, and Vyaire Medical, Inc.